{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:42:42Z","timestamp":1791394962500,"version":"4.3.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial prespecified an analysis to determine whether accounting for recurrent cardiovascular events in addition to first events modified understanding of the treatment effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Patients with stable coronary artery disease (CAD) and moderate or severe ischaemia on stress testing were randomized to either initial invasive (INV) or initial conservative (CON) management. The primary outcome was a composite of cardiovascular death, myocardial infarction (MI), and hospitalization for unstable angina, heart failure, or cardiac arrest. The Ghosh\u2013Lin method was used to estimate mean cumulative incidence of total events with death as a competing risk. The 5179 ISCHEMIA patients experienced 670 index events (318 INV, 352 CON) and 203 recurrent events (102 INV, 101 CON). A single primary event was observed in 9.8% of INV and 10.8% of CON patients while \u22652 primary events were observed in 2.5% and 2.8%, respectively. Patients with recurrent events were older; had more frequent hypertension, diabetes, prior MI, or cerebrovascular disease; and had more multivessel CAD. The average number of primary endpoint events per 100 patients over 4\u2009years was 18.2 in INV [95% confidence interval (CI) 15.8\u201320.9] and 19.7 in CON (95% CI 17.5\u201322.2), difference \u22121.5 (95% CI \u22125.0 to 2.0, P\u2009=\u20090.398). Comparable results were obtained when all-cause death was substituted for cardiovascular death and when stroke was added as an event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In stable CAD patients with moderate or severe myocardial ischaemia enrolled in ISCHEMIA, an initial INV treatment strategy did not prevent either net recurrent events or net total events more effectively than an initial CON strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>ISCHEMIA ClinicalTrials.gov number, NCT01471522, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01471522.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab509","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:17:20Z","timestamp":1629127040000},"page":"148-149","source":"Crossref","is-referenced-by-count":21,"title":["Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial"],"prefix":"10.1093","volume":"43","author":[{"given":"Jose L","family":"Lopez-Sendon","sequence":"first","affiliation":[{"name":"Cardiology department, Hospital Universitario La Paz, Idipaz, UAM, CIBER-CV , Paseo de la Castellana 261 , Madrid 28046,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D","family":"Cyr","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Duke University , 300 W. Morgan Street, Durham, NC,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6340-8087","authenticated-orcid":false,"given":"Daniel B","family":"Mark","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Duke University , 300 W. Morgan Street, Durham, NC,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripal","family":"Bangalore","sequence":"additional","affiliation":[{"name":"NYU Grossman School of Medicine , 530 First Avenue, New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Duke University , 300 W. Morgan Street, Durham, NC,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-6750","authenticated-orcid":false,"given":"Harvey D","family":"White","sequence":"additional","affiliation":[{"name":"Auckland City Hospital Green Lane Cardiovascular Services and University of Auckland , 2 Park Road, Grafton, Auckland 1023,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen P","family":"Alexander","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Duke University , 300 W. Morgan Street, Durham, NC,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghao","family":"Li","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Duke University , 300 W. Morgan Street, Durham, NC,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6107-1553","authenticated-orcid":false,"given":"Rajesh Goplan","family":"Nair","sequence":"additional","affiliation":[{"name":"Government Medical College , 48\/584, Subhag Sastrinagar, Thiruvananthapuram, Kerala 695002,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Demkow","sequence":"additional","affiliation":[{"name":"Department of Coronary and Structural Heart Diseases, National Institute of Cardiology , Alpejska 42, Warsaw 04-628,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8457-6351","authenticated-orcid":false,"given":"Jesus","family":"Peteiro","sequence":"additional","affiliation":[{"name":"CHUAC, Universidad de A Coru\u00f1a, CIBER-CV , As Xubias, 84, A Coruna 15006,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet S","family":"Wander","sequence":"additional","affiliation":[{"name":"Dayanand Medical College & Hospital , Civil Lines, Tagore Nagar, Ludhiana, Punjab 141001,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-0575","authenticated-orcid":false,"given":"Elena A","family":"Demchenko","sequence":"additional","affiliation":[{"name":"Almazov National Medical Research Centre , Ulitsa Akkuratova, 2, Saint-Petersburg 197341,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Gamma","sequence":"additional","affiliation":[{"name":"Broomfield Hospital , Court Rd, Broomfield, Chelmsford CM1 7ET,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Gadkari","sequence":"additional","affiliation":[{"name":"Kem Hospital Maharashtra , 489, Mudaliar Rd, Rasta Peth, Pune, Maharashtra 411011,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-7924","authenticated-orcid":false,"given":"Kian Keong","family":"Poh","sequence":"additional","affiliation":[{"name":"National University Heart Center Singapore , Singapore,","place":["Singapore"]},{"name":"Yong Loo Lin School of Medicine, National University of Singapore , 10 Medical Dr, Singapore,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuraia","family":"Nageh","sequence":"additional","affiliation":[{"name":"Southend University Hospital , Prittlewell Chase, Westcliff-on-Sea, Southend-on-Sea, Westcliff-on-Sea SS0 0RY, Southend, England,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Stone","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital , 75 Francis St, Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matyas","family":"Keltai","sequence":"additional","affiliation":[{"name":"Semmelweis University , Budapest, \u00dcll\u0151i \u00fat 26, 1085","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Sidhu","sequence":"additional","affiliation":[{"name":"Albany Medical College , 47 New Scotland Avenue, Physicians Pavilion, 2nd Floor, Albany, NY 12208,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6855-7305","authenticated-orcid":false,"given":"Jonathan D","family":"Newman","sequence":"additional","affiliation":[{"name":"NYU Grossman School of Medicine , 530 First Avenue, New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7145-8084","authenticated-orcid":false,"given":"William E","family":"Boden","sequence":"additional","affiliation":[{"name":"VA New England Healthcare System, Boston University School of Medicine , 150 South Huntington Avenue, Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmony R","family":"Reynolds","sequence":"additional","affiliation":[{"name":"NYU Grossman School of Medicine , 530 First Avenue, New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-5317","authenticated-orcid":false,"given":"Bernard R","family":"Chaitman","sequence":"additional","affiliation":[{"name":"St Louis University School of Medicine Center for Comprehensive Cardiovascular Care , 1034 S. Brentwood Blvd., Suite 1120, St. Louis, MO,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-5981","authenticated-orcid":false,"given":"Judith S","family":"Hochman","sequence":"additional","affiliation":[{"name":"NYU Grossman School of Medicine , 530 First Avenue, New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-8588","authenticated-orcid":false,"given":"David J","family":"Maron","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University , 300 Pasteur Drive, Falk CVRC 265, Stanford, CA 94305-5406,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute and Duke University , 300 W. Morgan Street, Durham, NC,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"2026071702164917100_ehab509-B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-18539-2","volume-title":"Fundamental of Clinical Trials","author":"Friedman","year":"2015","edition":"5th ed"},{"key":"2026071702164917100_ehab509-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/ijb-2017-0047","article-title":"Joint models of longitudinal and time-to-event data with more than one event time outcome: a review","volume":"14","author":"Hickey","year":"2018","journal-title":"Int J Biostat"},{"key":"2026071702164917100_ehab509-B3","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1002\/sim.7907","article-title":"Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study","volume":"37","author":"Claggett","year":"2018","journal-title":"Stat Med"},{"key":"2026071702164917100_ehab509-B4","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/eurheartj\/ehn362","article-title":"Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial","volume":"29","author":"Murphy","year":"2008","journal-title":"Eur Heart J"},{"key":"2026071702164917100_ehab509-B5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jacc.2015.10.077","article-title":"Reduction in total cardiovascular events with ezetimibe\/simvastatin post-acute coronary syndrome: the IMPROVE-IT trial","volume":"67","author":"Murphy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026071702164917100_ehab509-B6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamacardio.2019.3080","article-title":"Occurrence of first and recurrent major adverse cardiovascular events with liraglutide treatment among patients with type 2 diabetes and high risk of cardiovascular events: a post hoc analysis of a randomized clinical trial","volume":"4","author":"Verma","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026071702164917100_ehab509-B7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamacardio.2019.0886","article-title":"Effect of the PCSK9 inhibitor evolocumab on total cardiovascular events in patients with cardiovascular disease: a prespecified analysis from the FOURIER trial","volume":"4","author":"Murphy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026071702164917100_ehab509-B8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacc.2018.10.039","article-title":"Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial","volume":"73","author":"Szarek","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026071702164917100_ehab509-B9","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.jacc.2019.02.032","article-title":"Effects of icosapent ethyl on total ischemic events: from REDUCE-IT","volume":"73","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026071702164917100_ehab509-B10","doi-asserted-by":"crossref","first-page":"e001032","DOI":"10.1161\/JAHA.114.001032","article-title":"Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER","volume":"3","author":"White","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026071702164917100_ehab509-B11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2026071702164917100_ehab509-B12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2018.04.011","article-title":"International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: rationale and design","volume":"201","author":"Maron","year":"2018","journal-title":"Am Heart J"},{"key":"2026071702164917100_ehab509-B13","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026071702164917100_ehab509-B14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.0006-341X.2000.00554.x","article-title":"Nonparametric analysis of recurrent events and death","volume":"56","author":"Ghosh","year":"2000","journal-title":"Biometrics"},{"key":"2026071702164917100_ehab509-B15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"2026071702164917100_ehab509-B16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00392-018-1205-7","article-title":"Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints","volume":"107","author":"Rauch","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2026071702164917100_ehab509-B17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression-analysis of multivariate incomplete failure time data by modeling marginal distributions","volume":"84","author":"Wei","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"2026071702164917100_ehab509-B18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12874-017-0462-x","article-title":"A systematic comparison of recurrent event models for application to composite endpoints","volume":"18","author":"Ozga","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"2026071702164917100_ehab509-B19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hernan","year":"2010","journal-title":"Epidemiology"},{"key":"2026071702164917100_ehab509-B20","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2020.1267","article-title":"Why test for proportional hazards?","volume":"323","author":"Stensrud","year":"2020","journal-title":"JAMA"},{"key":"2026071702164917100_ehab509-B21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026071702164917100_ehab509-B22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.117.033065","article-title":"Comparison of time-to-first event and recurrent-event methods in randomized clinical trials","volume":"138","author":"Claggett","year":"2018","journal-title":"Circulation"},{"key":"2026071702164917100_ehab509-B23","doi-asserted-by":"crossref","first-page":"e006660","DOI":"10.1161\/CIRCOUTCOMES.120.006660","article-title":"Comparative methodological assessment of the randomized GLOBAL LEADERS trial using total ischemic and bleeding events","volume":"13","author":"Hara","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026071702164917100_ehab509-B24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The international conference on harmonization good clinical practice guideline","volume":"6","author":"Dixon","year":"1998","journal-title":"Qual Assur"},{"key":"2026071702164917100_ehab509-B25","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"2026071702164917100_ehab509-B26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41569-018-0006-z","article-title":"Revascularization in stable coronary disease: evidence and uncertainties","volume":"15","author":"Katritsis","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2026071702164917100_ehab509-B27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2026071702164917100_ehab509-B28","doi-asserted-by":"crossref","first-page":"e019114","DOI":"10.1161\/JAHA.120.019114","article-title":"Death and myocardial infarction following initial revascularization versus optimal medical therapy in chronic coronary syndromes with myocardial ischemia: a systematic review and meta-analysis of contemporary randomized controlled trials","volume":"10","author":"Soares","year":"2021","journal-title":"J Am Heart Assoc"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/2\/148\/46625162\/ehab509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/2\/148\/46625162\/ehab509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:16:57Z","timestamp":1784269017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/2\/148\/6368943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,9,13]]},"published-print":{"date-parts":[[2022,1,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab509","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,7]]},"published":{"date-parts":[[2021,9,13]]}}}